MiR-101 is downregulated in MCL as compared with a control group and an enhancer of the zeste 2 polycomb repressive complex 2 subunit (EZH2) protein, which is highly expressed in MCL. The gene discussed is EZH2; the disease is mantle cell lymphoma.